GlassScriptPhysician profile
William S Havron
NPI 1053522052
$7,434.81
in general payments reported to CMS, 2019-2025
15 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $1,556 · 2021: $1,228 · 2022: $2,007 · 2023: $521 · 2024: $1,630 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,540.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,343.07 | 2020-2022 | |
| Alphatec Spine, INC | $1,500.00 | 2024 | Other - Miscellaneous |
| Zimmer Biomet Holdings, INC. | $953.62 | 2021-2025 | Advantagerib, Ribfix Blu Advantage |
| Baxter Healthcare | $445.00 | 2021 | |
| Integra Lifesciences Corporation | $262.25 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $198.33 | 2020-2022 | |
| Davol INC. | $148.37 | 2020-2023 | Phasix Mesh |
| Acera Surgical, INC. | $133.11 | 2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $127.83 | 2025 | Novosorb Btm |
| Smith+Nephew, INC. | $127.47 | 2023 | Acticoat 4" X 4" |
| Angiodynamics, INC. | $103.12 | 2019 | |
| W. L. Gore & Associates, INC. | $41.25 | 2021 | |
| Tela Bio, INC. | $23.81 | 2022 | |
| Globus Medical, INC. | $23.62 | 2022 | |
| Kerecis Limited | $3.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Havron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.